NGOXIM Trademark

Trademark Overview


On Monday, November 9, 2020, a trademark application was filed for NGOXIM with the United States Patent and Trademark Office. The USPTO has given the NGOXIM trademark a serial number of 90307520. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 21, 2022. This trademark is owned by Therapyx, Inc.. The NGOXIM trademark is filed in the Pharmaceutical Products category with the following description:

Vaccine adjuvants; Vaccines
ngoxim

General Information


Serial Number90307520
Word MarkNGOXIM
Filing DateMonday, November 9, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 21, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 25, 2021

Trademark Statements


Goods and ServicesVaccine adjuvants; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 11, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTherapyx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLouisville, KY 40204

Party NameTherapyx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLouisville, KY 40204

Trademark Events


Event DateEvent Description
Tuesday, February 22, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 21, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 20, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 25, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 25, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 5, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 16, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 16, 2021ASSIGNED TO LIE
Friday, April 16, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 15, 2021ASSIGNED TO EXAMINER
Monday, January 11, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 12, 2020NEW APPLICATION ENTERED

Related Keywords


ngoxim vaccines adjuvants vaccine